The Week Ahead In Biotech: Adcom Test For Amarin’s Fish Oil Pill, Agile Awaits FDA Verdict

After the previous week’s strong gains, biotech stocks experienced a slight loss of momentum this week. The week saw a few clinical trial readouts and a slew of earnings  reports from small- to mid-sized …